Related Experiment Video
Updated: Aug 6, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
Conditional activation of IL-12 through a Fibronectin-EDB dependent switch gate
Josephine D Kahn1, Kothai Parthiban2, Peter Slavny2
1Third Rock Ventures, Boston, MA, USA.
Potent immune-activators, such as interleukin-12 (IL-12) have been challenging to develop for the treatment of solid tumors due to high systemic toxicity. To expand the therapeutic window achievable with IL-12, we engineered a novel and reversible antibody format, comprising a switch arm and targeting arm, that permits conditional activation of IL12 only in the presence of the pan-tumor matrix antigen Fibronectin-EDB (FN-EDB). The switch arm is formed by a dual specificity Fab that binds to tethered IL-12 or FN-EDB in a competitive manner. The FN-EDB targeting arm promotes the avidity‑driven unveiling of IL-12 that is tethered to the switch arm. We employed a quantitative systems pharmacology (QSP) model to define binding parameters required for Switch-IL-12 activity and use a phage screening and rational library design process to generate switch binders with the desired binding profiles. We show that our in vitro functional data support FN-EDB dependent Switch-IL-12 activity and incorporate these data into our QSP model to further refine and expand the therapeutic index of Switch-IL-12.
Potent immune-activators, such as interleukin-12 (IL-12) have been challenging to develop for the treatment of solid tumors due to high systemic toxicity. To expand the therapeutic window achievable with IL-12, we engineered a novel and reversible antibody format, comprising a switch arm and targeting arm, that permits conditional activation of IL12 only in the presence of the pan-tumor matrix antigen Fibronectin-EDB (FN-EDB). The switch arm is formed by a dual specificity Fab that binds to tethered IL-12 or FN-EDB in a competitive manner. The FN-EDB targeting arm promotes the avidity‑driven unveiling of IL-12 that is tethered to the switch arm. We employed a quantitative systems pharmacology (QSP) model to define binding parameters required for Switch-IL-12 activity and use a phage screening and rational library design process to generate switch binders with the desired binding profiles. We show that our in vitro functional data support FN-EDB dependent Switch-IL-12 activity and incorporate these data into our QSP model to further refine and expand the therapeutic index of Switch-IL-12.
Related Concept Videos
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Intracellular Signaling Affects Focal Adhesions
Some...
Fibronectins Connect Cells with ECM
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
Selectins
TGF - β Signaling Pathway
The JAK-STAT Signaling Pathway

